These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 8351709)

  • 1. Post-transplant immune serological markers may be predictive of chronic rejection.
    Kerman RH
    Ann Transplant; 2000; 5(2):24-8. PubMed ID: 11217203
    [No Abstract]   [Full Text] [Related]  

  • 2. [How we do anti-HLA antibodies detection of quality control better].
    He J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):265-269. PubMed ID: 31104435
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of HLA and race on long-term cadaveric renal transplantation.
    Bryan CF; Aeder MI; Helling TS; Hughes J; Luger AM; Nelson PW; Pierce GE; Shield CF; Warady B
    Transplant Proc; 1992 Dec; 24(6):2451-3. PubMed ID: 1465826
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients.
    Ross W; Solomon H; Reese J; Fairchild R; Garvin P; Kurtz M
    Transplant Proc; 1993 Aug; 25(4):2408-10. PubMed ID: 8356616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in kidney allograft rejection.
    Sujirachato K; Chiewsilp P; Jirasiritham S; Mongkolsuk T; Sumethkul V
    Transplant Proc; 1996 Jun; 28(3):1272. PubMed ID: 8658656
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of protective genes in the HLA system on renal graft survival.
    Mikłaszewicz A; Giedrys-Kalemba S; Teodorczyk U; Hałasa J; Goertz K; Zieliński S; Ostrowski M; Kostyrka R; Lapis J; Kulig G; Kulig T; Kruszewski T; Kozłowski M; Lewiński D; Grzywacz B; Grzywacz M; Kuprjanowicz L
    Transplant Proc; 2000 Sep; 32(6):1337-8. PubMed ID: 10995972
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of discrepancies between serologic and DNA-RFLP typing for HLA-DR in kidney graft recipients.
    Mytilineos J; Scherer S; Trejaut J; Dunckley H; Chapman J; Fischer G; Fae I; Middleton D; Savage D; Bignon JD
    Transplant Proc; 1992 Dec; 24(6):2478-9. PubMed ID: 1361257
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of HLA matching for cadaveric renal transplants in the cyclosporine era.
    Hunsicker LG; Held PJ
    Semin Nephrol; 1992 Jul; 12(4):293-303. PubMed ID: 1410858
    [No Abstract]   [Full Text] [Related]  

  • 9. The graft survival curve: ideology and rhetoric.
    Guttmann RD
    Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of late acute rejection after cadaveric kidney transplantation.
    Joseph JT; Kingsmore DB; Junor BJ; Briggs JD; Mun Woo Y; Jaques BC; Hamilton DN; Jardine AG; Jindal RM
    Clin Transplant; 2001 Aug; 15(4):221-7. PubMed ID: 11683814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune risk factors: impact on the incidence and diagnosis of rejection.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; Podbielski J; Williams J; Kahan BD
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):23-5. PubMed ID: 8351709
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.